Can bupropion cause muscle twitches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Bupropion Cause Muscle Twitches?

Yes, bupropion can cause muscle twitches, though this is an uncommon adverse effect. The FDA drug label specifically lists "twitch" as a documented adverse reaction, occurring in 1-2% of patients in clinical trials 1.

Evidence from Clinical Trials and FDA Labeling

The FDA-approved prescribing information for bupropion documents muscle twitching as a recognized adverse effect. In controlled trials comparing different formulations:

  • Immediate-release bupropion (300 mg/day): Twitching occurred in approximately 1% of patients
  • Immediate-release bupropion (400 mg/day): Twitching increased to 2% of patients
  • Placebo group: No twitching reported 1

This demonstrates a clear dose-response relationship, with higher doses associated with increased risk of muscle twitching.

Related Movement Disorders with Bupropion

Beyond simple muscle twitches, bupropion has been associated with more significant movement abnormalities in case reports and postmarketing surveillance:

Myoclonus

Myoclonus (sudden, involuntary muscle jerks) has been documented with bupropion use. A 2023 case report described a patient who developed upper limb myoclonus and facial twitching after doubling his bupropion dose to 300 mg twice daily without medical supervision 2. The symptoms resolved within 24 hours after discontinuing bupropion and initiating clonazepam. Only 8 cases of bupropion-induced myoclonus have been reported in the literature, with most patients fully recovering after drug discontinuation 2.

Dystonia

Acute dystonia (sustained muscle contractions) has been reported, including cases of facial dystonia and temporomandibular joint involvement 3, 4. One case demonstrated a clear dose-dependent relationship, with dystonic symptoms appearing within 24-48 hours of increasing the dose from 150 mg to 300 mg daily 4.

Tics

A 2026 case report documented new-onset motor and vocal tics (clapping, whistling, laughing) in a patient with no prior tic disorder history after starting bupropion XL 5. The tics completely resolved upon discontinuation.

Mechanism and Clinical Context

The mechanism underlying bupropion-induced movement disorders likely relates to its dopaminergic effects. Bupropion inhibits dopamine and norepinephrine reuptake 1. Movement disorders are typically associated with dopaminergic dysfunction in the basal ganglia, similar to mechanisms seen with antipsychotic medications 4.

The FDA label notes additional neurological adverse effects that may co-occur with twitching, including:

  • Tremor (1-6% depending on dose)
  • Hyperkinesia
  • Hypertonia
  • Extrapyramidal syndrome
  • Dyskinesia 1

Clinical Recommendations

If a patient develops muscle twitches on bupropion:

  1. Assess the severity and impact on function - Simple, occasional twitches may not require intervention if the patient is otherwise benefiting from treatment

  2. Consider dose reduction - Given the dose-response relationship demonstrated in clinical trials, reducing to the lowest effective dose may resolve symptoms while maintaining therapeutic benefit 1, 4

  3. Discontinue if symptoms are bothersome or progressive - All reported cases of more severe movement disorders (myoclonus, dystonia, tics) resolved with drug discontinuation 5, 2, 3, 4

  4. Rule out other causes - Ensure twitching is not due to other medications, metabolic abnormalities, or neurological conditions

  5. Monitor for seizure risk - Bupropion lowers seizure threshold, and movement abnormalities could potentially herald more serious neurological complications 6, 7

Important Caveats

  • Maximum dose should never exceed 450 mg/day due to increased seizure risk 1
  • Patients with seizure disorders, eating disorders (bulimia), or those undergoing alcohol/benzodiazepine withdrawal should not receive bupropion due to further lowering of seizure threshold 6, 7
  • The combination of bupropion with other serotonergic agents has been associated with serotonin syndrome, which can present with myoclonus 8

References

Research

Bupropion-induced acute dystonia.

The Annals of pharmacotherapy, 2002

Guideline

smoking cessation, version 1.2016, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

Guideline

american association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.